Life-Sciences-Benelux.com
The Benelux Life Sciences Web Portal

This is a free web portal for the life sciences in Belgium, The Netherlands and Luxembourg... » read more

Artios Pharma Closes £110m Series C Led Round (2021-07-27)
> Funding propels Artios’ ability to progress beyond synthetic lethality and to continue the exploitation of the full spectrum of oncology vulnerabilities presented by the DNA Damage Response through deployment of Artios’ DDR-based platform and small molecule drug ...
SynOx Therapeutics Appoints New Chairman & New CEO (2021-07-27)
> Plans to initiate a pivotal trial for patients suffering from Tenosynovial Giant Cell Tumours (TGCT) > Follows €37 M Series A investment to progress emactuzumab, a potentially best-in-class CSF-1R antibody licensed on an exclusive, worldwide basis from Roche ...
Byondis and Glycotope Enter Platform Access Agreement (2021-07-27)
Byondis B.V., an independent, clinical stage biopharmaceutical company creating precision medicines, and Glycotope, a biotechnology company developing antibodies against proteins carrying tumor-specific carbohydrate structures, have entered into a platform access a...
Slingshot Biosciences Announces $23m Series A Financing (2021-07-22)
Building synthetic cells to broaden access to advanced diagnostics and therapeutics Slingshot Biosciences, a biotechnology company building the world’s first on-demand synthetic cell platform, today announced the closing of $23 million in a Series A financing....
Coave Tx (Horama): €21.2m Series B Round Extension (2021-07-21)
- Coave Therapeutics is the new name for Horama and reflects its new emphasis on AAV-Ligand Conjugate based vectors for CNS diseases alongside Ocular diseases - Funding led by Seroba Life Sciences and supported by Théa Open Innovation, eureKARE and existing shar...
Mimetas & Roche Partner to Develop Human Disease Models (2021-07-06)
> Risk-sharing alliance on tailor-made phenotypic models for IBD and HBV > Upfront payment and milestone payments for MIMETAS > Access to know-how on novel disease models and assays for Roche > Option to exclusively license of disease models and assays for...
MoonLake Appoints Jorge Santos da Silva as CEO (2021-07-01)
> Expert leadership team will drive planned acceleration of clinical development program for potentially best-in-class Tri-specific Nanobody® Sonelokimab in multiple indications > Sonelokimab in-licensed from Merck KGaA, Darmstadt, Germany, in May 2021 with goal...
Promethera Raises €20m Round Led by Tata Health (CN) (2021-06-30)
This new fundraising secures the financing of its Phase IIB study for HepaStem® in its flagship indication, Acute on Chronic Liver Failure (ACLF), a severe liver disease affecting more than 50,000 patients each year in EU and USA , with a 40% to 70% mortality ...
Novalis Biotech Closes €25m Biotech Acceleration Fund (2021-06-30)
Novalis Biotech, an early-stage venture capital investor in technologies aimed at revolutionizing healthcare, announced today the closing of its €25 million second fund, the Novalis Biotech Acceleration Fund. Both new and returning investors have participated in th...
Catalent Acquires iPSCs Company RheinCell Therapeutics (2021-06-24)
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has reached an agreement to acquire RheinCell Ther...

Life-Sciences-Benelux.com is your doorway to the Benelux life sciences!

[LSBNL] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Benelux countries Belgium, The Netherlands and Luxembourg.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSBNL] is 100% Made in Germany!

» Start here with the latest News!

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)